Reaktion #218731
ord-3b904661dd2c4aa69e8d5b38aafb0227
Reaktionsgleichung
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Aufarbeitung
- 1SonstigeA 50-fold dilution of this was prepared in RPMI and serial dilutions
- 2Sonstigewere prepared from this solution
- 3workup.ADDITION10 μl of the 50-fold diluted stock, or dilutions of it, were added to the well
- 4Sonstigeto give
- 5Einengenconcentrations in the assay
- 6Sonstigeprepared from human peripheral blood from a single donor, in RPMI1640 medium
- 7EinengenPhorbol myristate acetate (PMA) (0.5 ng/ml final concentration) and ionomycin (500 ng/ml final
- 8Einengenconcentration)
- 9workup.ADDITIONwere added to these cells in supplemented RPMI1640 medium (as above) so that the final volume of the assay
- 10workup.ADDITION3H-Thymidine (0.5 μCi) was added for the final 6 hours of the incubation
Vorschrift
The assay for PMA/ionomycin-stimulated PBMC proliferation was performed in 96-well flat bottomed microtitre plates. Compounds were prepared as 10 mM stock solutions in dimethyl sulfoxide. A 50-fold dilution of this was prepared in RPMI and serial dilutions were prepared from this solution. 10 μl of the 50-fold diluted stock, or dilutions of it, were added to the well to give concentrations in the assay starting at 9.5 μM and going down. Into each well was placed 1×105 PBMC, prepared from human peripheral blood from a single donor, in RPMI1640 medium supplemented with 10% human serum, 2 mM glutamine and penicillin/streptomycin. Phorbol myristate acetate (PMA) (0.5 ng/ml final concentration) and ionomycin (500 ng/ml final concentration) were added to these cells in supplemented RPMI1640 medium (as above) so that the final volume of the assay was 0.2 ml. The cells were incubated at 37° C. in a humidified atmosphere at 5% carbon dioxide for 72 hours. 3H-Thymidine (0.5 μCi) was added for the final 6 hours of the incubation. The level of radioactivity incorporated by the cells was then determined and this is a measure of proliferation.